
11 - 50 employees
Founded 2018
𧬠Biotechnology
π Pharmaceuticals
π₯ Funding within the last year
π° $402M Post-IPO Equity on 2025-12
Biotechnology β’ Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The companyβs pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
π October 30
π California β Remote
π΅ $180k - $195k / year
β° Full Time
π΄ Lead
π Compliance
π» Ghost score 0%
Where this job comes from
Posted on Belite Bio's careers page β, not through a job board
First seen by Remote Rocketship October 30
Still open on Belite Bio's site. Checked 1 hour ago.

11 - 50 employees
Founded 2018
𧬠Biotechnology
π Pharmaceuticals
π₯ Funding within the last year
π° $402M Post-IPO Equity on 2025-12
Biotechnology β’ Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The companyβs pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
β’ Lead the development and implementation of global CMC regulatory strategies for small-molecule products across development, registration, commercialization, and post-approval lifecycle management β’ Serve as the primary Regulatory CMC partner to Pharmaceutical Development, Manufacturing, Quality, Supply Chain, and other cross-functional functions β’ Provide regulatory guidance for drug substance and drug product manufacturing, formulation, manufacturing process, analytical methods, specifications, stability, packaging, container closure systems, and related CMC activities β’ Assess proposed manufacturing and product changes and develop global regulatory strategies and implementation plans β’ Provide regulatory support for manufacturing scale-up, process optimization, technology transfers, manufacturing site changes, formulation changes, specification changes, analytical method changes, packaging changes, and other product lifecycle activities β’ Advise CMC and Quality teams on the regulatory impact of change controls β’ Identify CMC regulatory risks and provide risk-based recommendations supporting compliance, product quality, and continuity of commercial supply β’ Review, author when applicable, and coordinate CMC content for NDAs, amendments, supplements, annual reports, health authority responses, and other CMC-related submissions β’ Lead preparation and review of post-approval CMC submissions, including PAS, CBE/CBE-30, Annual Reportable changes, and other U.S. reporting categories β’ Develop and execute global post-approval change strategies, including EU Type IA, Type IB, and Type II variations β’ Apply SUPAC, FDA, EMA, ICH, and other global regulatory guidelines β’ Review CMC documents from technical functions, contract manufacturers, testing laboratories, and external partners β’ Ensure consistency of CMC information across submissions, source documents, approved applications, and global dossiers β’ Support preparation and maintenance of Module 3 and other CMC components of global regulatory applications β’ Support responses to health authority CMC questions and information requests β’ Provide regulatory leadership for CMC lifecycle management of commercially marketed products β’ Evaluate manufacturing, process, site, equipment, formulation, analytical, specification, stability, packaging, and supply-chain changes β’ Integrate regulatory requirements into pharmaceutical change-control processes β’ Develop global implementation strategies accounting for differences in approval timelines and reporting requirements β’ Maintain awareness of regulatory commitments, approved conditions, and country-specific requirements β’ Lead or support CMC interactions with FDA and other global health authorities β’ Develop briefing materials, regulatory positions, responses, and supporting documentation for health authority meetings and written communications β’ Represent Regulatory CMC in discussions regarding manufacturing changes, comparability, specifications, analytical methods, stability, process validation, and other CMC topics β’ Monitor evolving FDA, EMA, ICH, and other global CMC regulations and guidance β’ Support regulatory assessment of investigations, deviations, out-of-specification trends, manufacturing changes, and other quality or technical matters β’ Provide regulatory input into comparability strategies and supporting data packages for post-approval manufacturing changes β’ Communicate regulatory developments and emerging expectations to CMC and senior leadership
β’ Bachelor's degree in Chemistry, Pharmaceutical Sciences, Pharmacy, Chemical Engineering, Biology, or a related scientific discipline required β’ Advanced scientific degree such as MS, PharmD, or PhD preferred β’ 10+ years of Regulatory Affairs experience in the pharmaceutical or biopharmaceutical industry, with substantial experience focused on CMC regulatory affairs β’ Demonstrated Regulatory CMC experience with small-molecule drug products required β’ Prior experience supporting commercially marketed products and post-approval CMC lifecycle management required β’ Demonstrated experience with U.S. post-approval change requirements, including SUPAC, PAS, CBE/CBE-30, and Annual Reportable changes β’ Strong knowledge of global post-approval regulatory requirements, including EU variation classifications and procedures (Type IA, IB, and II) β’ Demonstrated experience preparing, reviewing, and managing CMC sections of NDAs and other marketing applications, supplements, variations, amendments, and responses to health authority information requests β’ Strong understanding of small-molecule pharmaceutical development and manufacturing, including drug substance and drug product manufacturing, process validation, scale-up, technology transfer, analytical methods, specifications, stability, and packaging β’ Experience assessing regulatory impact and reporting requirements for manufacturing site transfers, process changes, formulation changes, analytical method changes, specification changes, scale changes, and other commercial manufacturing changes β’ Working knowledge of FDA, EMA, ICH, and other major global CMC regulatory requirements and guidelines β’ Experience working with internal manufacturing organizations, Quality functions, CMOs/CDMOs, testing laboratories, and other external technical partners β’ Experience interacting directly with FDA and/or other global health authorities on CMC matters preferred β’ Experience supporting solid oral dosage forms preferred β’ Strong scientific and regulatory judgment with the ability to independently assess complex CMC changes and translate technical information into clear regulatory strategies β’ Excellent technical writing and regulatory submission writing skills β’ Strong critical-review skills and demonstrated ability to identify gaps, inconsistencies, and regulatory risks within CMC documentation β’ Ability to provide clear, practical regulatory recommendations to CMC, Quality, Manufacturing, Supply Chain, and senior leadership β’ Strong written and verbal communication skills with the ability to influence cross-functional teams β’ Detail-oriented, proactive, and able to manage multiple priorities in a fast-paced, matrixed environment β’ Strong organizational and project-management capabilities with demonstrated ability to manage multiple submissions and global implementation timelines β’ Experience working effectively across global teams and time zones
β’ Annual incentive bonuses β’ Equity participation β’ Health insurance β’ Dental insurance β’ Vision insurance β’ 401(k) β’ Paid time off β’ Reasonable accommodations for individuals with disabilities
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π October 30
Claims compliance leader overseeing regulatory inquiries, analyst teams, and claims processes. Improving regulatory performance for Oscar Health, a technology-driven health insurer.
πΊπΈ United States β Remote
π΅ $134.1k - $176.1k / year
π° $355M Post-IPO Debt - Oscar Health on 2025-09
β° Full Time
π Senior
π΄ Lead
π Compliance
π¦ H1B Visa Sponsor
π October 30
Claims compliance leader guiding regulatory investigations and analyst teams for Oscar Health, a technology-driven health insurer. Improving claims processes, compliance, and regulatory performance.
πΊπΈ United States β Remote
π΅ $134.1k - $176.1k / year
π° $355M Post-IPO Debt - Oscar Health on 2025-09
β° Full Time
π Senior
π΄ Lead
π Compliance
π¦ H1B Visa Sponsor
π October 30
Director managing DISAβs uranium remediation, licensing, and environmental compliance operations. Coordinating radioactive materials permits with federal and state regulators while advancing HPSA projects.
πΊπΈ United States β Remote
π΅ $120k - $160k / year
π₯ Funding within the last year
π° $105M Private Equity Round on 2026-08
β° Full Time
π΄ Lead
π Compliance
π October 29
Amgen regulatory director leading global strategies for obesity and cardiometabolic medicines. Guiding submissions, Health Authority interactions, and cross-functional regulatory teams.
πΊπΈ United States β Remote
π΅ $195.6k - $264.7k / year
π° $28.5G Post-IPO Debt on 2022-12
β° Full Time
π Senior
π΄ Lead
π Compliance
π¦ H1B Visa Sponsor
π October 29
Regulatory Policy and Intelligence Associate Director shaping U.S. and international medicine regulations for Amgen, a global biotechnology company. Leading policy positions, reform initiatives, and stakeholder engagement.
πΊπΈ United States β Remote
π΅ $155.4k - $210.2k / year
π° $28.5G Post-IPO Debt on 2022-12
β° Full Time
π Senior
π΄ Lead
π Compliance
π¦ H1B Visa Sponsor